Bearbmagovva

Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation

Furkejuvvon:
Publikašuvnnas:Pharmaceuticals vol. 18, no. 8 (2025), p. 1157-1189
Váldodahkki: Niazi, Sarfaraz K
Almmustuhtton:
MDPI AG
Fáttát:
Food & Drug Administration > FDA
United States > US
Germany
Monoclonal antibodies
Product quality
Collaboration
Real time
Batch processes
Process controls
Biological products
Pharmaceutical industry
Capital expenditures
Batch processing
Manufacturing
Cost control
19th century
Product testing
Liŋkkat:Citation/Abstract
Full Text + Graphics
Full Text - PDF
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
Lasit vuosttaš kommeantta. Visot kommeanttat leat almmolaččat.!
Čálihuva vuohččan sisa